Health Archive

CSOFT’s health sciences blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.

Home 9 Health 9 Archive
78 Million People With Dementia by 2030, WHO Predicts

78 Million People With Dementia by 2030, WHO Predicts

Dubbed a global health concern, The WHO (World Health Organization) has projected that the number of people living with dementia will increase to 78 million by the year 2030 and will cost the global economy $1.3 trillion p/a. Currently, there are over 55 million...

EU Vaccinated 70% of Adult Population Against COVID-19

EU Vaccinated 70% of Adult Population Against COVID-19

The European Commission announced that 70% of adults in the European Union (EU) are fully vaccinated against COVID-19, meeting the target that was initially set in January 2021, at the start of the vaccine rollout. This milestone marks a success for the EU's...

Eagle Receives USPTO Additional Patent for Bendamustine

Eagle Receives USPTO Additional Patent for Bendamustine

Eagle Pharmaceuticals have been granted their U.S. Patent No. 11,103,483 titled, “Formulations of Bendamustine”, by the U.S. Patent and Trademark Office (USPTO). Eagle plans to submit this patent to be included in the FDA’s (Food and Drug Administration’s) Orange Book...

Pfizer COVID-19 Vaccine Received Full FDA Approval

Pfizer COVID-19 Vaccine Received Full FDA Approval

Marketed under the name, Comirnaty, The US FDA (Food and Drug Administration) granted the Pfizer-BioNTech COVID-19 vaccine full approval yesterday, the first COVID-19 vaccine to become fully licensed in the US. In the US, the vaccine is now approved for people aged 16...

FDA Approves Abbott’s Amplatzer Amulet Fibrillation

FDA Approves Abbott’s Amplatzer Amulet Fibrillation

The US FDA (Food and Drug Administration) has approved Abbott’s Amplatzer Amulet left atrial appendage occlude for the treatment of nonvalvular atrial fibrillation in people with a higher risk of stroke and systemic embolism. Abbott's Amulet is characterized by its...

Rocket to Resume Clinical Trial following FDA Hold Lift

Rocket to Resume Clinical Trial following FDA Hold Lift

The US FDA (Food and Drug Administration) has lifted their clinical hold on Rocket Pharmaceuticals for their experimental gene therapy program for the treatment of Danon disease. Following the decision, Rocket announced it will resume patient enrollment later this...

CytoDyn HIV Justification Report: Guidance From FDA

CytoDyn HIV Justification Report: Guidance From FDA

The U.S FDA (Food and Drug Administration) has provided CytoDyn with guidance on its recent HIV BLA dose justification report, a crucial part of the company’s resubmission for its Biologics License Application (BLA) for HIV. CytoDyn is known for specializing in...

FDA Clearance: Syntr Health Technologies SyntrFuge System

FDA Clearance: Syntr Health Technologies SyntrFuge System

Syntr Health Technologies has been granted clearance from the US FDA (Food and Drug Administration) for their SyntrFuge System for surgical use when transferring a patient’s adipose (fat) tissue. Syntr Health Technologies, a medical device company that focuses on the...